Prelude Corporation's genomic test has been adopted in various US centers and is driving clinical decision-making, affiliated with Memorial Sloan Kettering Cancer Center.
2 reports, 2 independent
Updated Jun 12
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 2
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Prelude Corporation's genomic test has been adopted in various US centers and is driving clinical decision-making, affiliated with Memorial Sloan Kettering Cancer Center.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Prelude Therapeutics' CSO, Peggy Scherle, confirmed Prelude's participation in a conference in New York City.Sub-event
Prelude Corporation genomic test adopted in US centers, affiliated with MSKCC.1 source
Keep exploring
The entities involved
-
Memorial Sloan Kettering Cancer Center
cancer treatment and research institution in New York City, United States